OncoZenge AB (publ) announced the formation of an Advisory Board of renowned scientists and clinicians with expertise in oral medicine and cancer. The Advisory Board will provide strategic guidance and consultation to OncoZenge as it advances its research and development, with a focus on advancing BupiZenge(TM) through phase III studies and eventual market approval. The board's members bring a wealth of experience in oral medicine, radiotherapy and chemotherapies, including a deep understanding of the cancer care applied for patients suffering from oral mucositis.

The founding members of the Advisory Board include Dr Stephen Sonis and Dr Pooja Nandwani Patel. Dr Stephen Sonis, Professor of Oral Medicine at Harvard, Dr Pooja Nandwani Patel, Head of Department of Radiation Oncology, Sterling Cancer Hospital, India . Dr. Sonis is a senior academic at Harvard, Brigham and Women's Hospital and the Dana-Farber Cancer Institute and a world-renowned expert on tissue toxicities of cancer therapy.  His development of highly translational models has enabled the investigation of cancer regimen-related tissue toxicities and catalyzed development of potential therapies and innovative omics-based analytical approaches to clinically actionable outcomes to personalize therapy.

Dr. Sonis is the former President of Triad, an international not-for-profit company which focused on the adverse health and economic outcomes of cancer treatment toxicities and has served as a special employee of the FDA.  He is a founder of Biomodels, a pre-clinical research organization, which was spun out of Brigham and Women's Hospital in 1997 and has assisted in the development of drugs, devices, and biologicals for a wide range of indications including mucositis. A spin-off, Primary Endpoint Solutions (PES) assists companies throughout the clinical development process.  Dr. Sonis  holds several patents and is the author of more than 300 original publications, reviews, and chapters and 11 books.  He received his DMD from Tufts, completed his DMSc and residency at Harvard, and his postdoctoral training in tumor immunology at Oxford where he was a Knox Fellow.   Dr. Pooja Nandwani Patel is a Radiation Oncologist working in the field of cancer since 2005. Currently, she is a Senior Consultant and Head of the Radiation Oncology Department at Sterling Cancer Hospital, India.

She is a very passionate Radiation Oncologist with patient care as the main focus in her daily practice. She has received the Most Promising Young Oncologist Award from Indian Cancer Society in 2012. She has been the recipient of many popular fellowships from AROI (Association of Radiation Oncologists of India), ASTRO (American Society of Radiation, ESTRO (European Society for Radiotherapy & Oncology), IGCS (International Gynecological Cancer Society), SNO (Society of NeuroOncology) and ASCO (American Society of Clinical Oncology).

She has been trained at reputed international cancer centres abroad including Christie School of Oncology, NHS Foundation Trust, Manchester, England, Mannheim University, Mannheim, Germany, Newcastle upon Tyne Hospital, NHS Foundation Trust, England, United Kingdom, Kaiser Permanente Medical Hospital, Santa Clara, California, USA, Princess Margaret Hospital, Toronto, Canada, Long Beach Memorial Medical Centre, Long Beach, USA and The Methodist Hospital, Houston, USA Her primary research interests involve head and neck malignancies, gynecological malignancies, breast cancer, prostate cancer and brain tumors. She is very keen to utilize her acquired knowledge through various international fellowships and trainings done abroad, into clinical practice for the betterment of her patients.